Stay updated on VX-152 Combo Safety in CF Adults Clinical Trial
Sign up to get notified when there's something new on the VX-152 Combo Safety in CF Adults Clinical Trial page.

Latest updates to the VX-152 Combo Safety in CF Adults Clinical Trial page
- Check4 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2 and removed the Back to Top element; no other substantive content changes.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a new facility name and location in St. Louis, Missouri, along with new resources related to cystic fibrosis and drug safety. However, several previous location details and specific drug information have been removed.SummaryDifference3%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check46 days agoChange DetectedThe page has been updated to reflect a new version, v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to VX-152 Combo Safety in CF Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX-152 Combo Safety in CF Adults Clinical Trial page.